Replies to post #4612 on BioSante Pharmaceuticals, Inc. (BPAX)

[Rustler]

We need some solid press releases from BioSante bolstering and rebuilding some of the confidence that it shattered through its Libigel condundrum. We could also use some realistic projections on how BPAX intends to service its debt and continue as not only a going concern, but a growing, vibrant, profitable company.